Prostate Cancer Diagnosis Articles & Analysis
8 articles found
It is important for labs of all shapes and sizes to consider investing in the digital transformation process if they want to ensure they can keep pace with the challenges modern cancer diagnosis imposes upon strained pathologists. The Problems in Pathology Today First and foremost, pathologists today are facing increasing workloads. ...
That is why Paige is working with international organizations, like the University of Oxford and Prostate Cancer UK, to change the prostate cancer landscape this Movember and beyond. First, we begin by understanding whether AI might help pathologists address the challenges they face in prostate ...
Real-world data shows that at a 94% sensitivity level for prostate cancer ClarityDX Prostate® is 147% more specific than the PSA test for predicting clinically significant prostate cancer. ...
” Implementing ClarityDX Bladder as a highly accurate, noninvasive bladder cancer test will allow for straightforward diagnosis of low-grade bladder cancers and more rapid detection of aggressive bladder cancer before cystoscopy. ...
Consistent with pandemic shutdowns and initial fear, several studies show a similar decreasing trend in cancer diagnosis, with prostate cancer dropping the most.2 During the first wave, patient visits dropped and then dropped even lower before starting to recover to pre-pandemic volume. ...
Exact Imaging is a leading developer of ultra-high-resolution micro-ultrasound diagnostic technologies Micro-ultrasound ExactVu™ is the only ultrasound-based imaging tool with published data demonstrating prostate cancer diagnostic capabilities similar to MRI Combination of Exact Imaging’s micro-ultrasound and EDAP’s Focal One® ...
The Yukon chapter of Ride For Dad says a new blood test developed by an Alberta-based company could save the lives of men at risk of prostate cancer. (iStock/Getty Images) A bio-technology company based in Alberta is testing a new process that could result in fewer Yukon men travelling out of territory for prostate cancer biopsies. Private research company Nanostics Inc. and the University of ...
Abstract Background: Prostate cancer (PCa) diagnosis is challenging because efforts for effective, timely treatment of men with significant cancer typically result in over-diagnosis and repeat biopsies. ...